Mieke H van Marion et al.
Journal of molecular and cellular cardiology, 87, 79-91 (2015-08-19)
Cardiomyocyte progenitor cells (CMPCs) are a candidate cell source for cardiac regenerative therapy. However, like other stem cells, after transplantation in the heart, cell retention and differentiation capacity of the CMPCs are low. Combining cells with biomaterials might overcome this